Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiation.

Seminars in oncology

Volumn 24, Issue 4 Suppl 12, 1997, Pages

  Bonomi, P ^a   Faber, L P ^a   Warren, W ^a   Lincoln, S ^a   LaFollette, S ^a   Sharma, M ^a   Recine, D ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; PACLITAXEL;

ARTICLE; CANCER STAGING; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HUMAN; LUNG DISEASE; LUNG RESECTION; LUNG TUMOR; MALE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 1 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; RADIATION DOSE; RADIOTHERAPY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PACLITAXEL; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 0031203271     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)